NTRK1 and neoplasm: By serial dilutions with the tumor sample 28, which is negative for RET and TRK rearrangements, we demonstrated that the PTC-MA assay is able to detect the presence of fusion genes with high sensitivity, also when they were present in 5% only of the total cDNA (Supplemental Fig. 2b).